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Abstract
Methicillin resistant Staphylococcus aureus (MRSA) infection can cause significant morbidity and mortality in neonates. We investigated a
nosocomial MRSA outbreak in a neonatal intensive care unit (NICU), using a novel typing method. Following two fatal cases, in May
2011, a prospective outbreak investigation was conducted, involving neonates, mothers and healthcare workers in a large tertiary NICU
in Sydney. MRSA isolates were characterized by antimicrobial susceptibility testing, a multiplex PCR-based reverse line blot (mPCR/RLB)
binary typing system and other molecular typing methods. Over 7 months, 14 neonates were colonized with MRSA and six infected:
three with superficial lesions and three with life-threatening disease, including the two index cases, who died despite empirical treat-
ment with vancomycin. Isolates from 15 neonates were indistinguishable by RLB typing and identified as a PVL-producing ST22 SCCmec
IV MRSA strain, which was resistant to gentamicin and trimethoprim-sulphamethoxazole. The outbreak strain was also isolated from
one healthcare worker, one environmental swab and one father, but the source remained obscure. During the same period several dif-
ferent non-multiresistant and multiresistant MRSA strains were isolated from five neonates, five mothers (including two whose infants
were colonized with the outbreak strain), one father, three healthcare workers and two environmental swabs. Rapid turnaround time
of typing results allowed us to recognize and define the outbreak and implement targeted infection control interventions. PVL-producing
ST22 SCCmec IV MRSA appears to be a virulent and highly transmissible pathogen in the NICU, which was difficult to control.
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This is the first description of an outbreak due to a rare clone of
MRSA using a novel typing system. This highly discriminatory method
is inexpensive, high throughput, has a turnaround time of 12 h, and
enabled targeted infection control interventions.
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) has the
potential to cause severe disease and sustained nosocomial
outbreaks [1–3] among premature infants in neonatal
intensive care units (NICUs). Its early recognition is essen-
tial to prevent transmission and ensure optimal treatment
[4].
The mother is often assumed to be the source of MRSA
in a colonized neonate, but nosocomial transmission from
fomites or via healthcare workers (HCWs) also occurs.
Transmission routes can be identified with the aid of molec-
ular typing [3].
In May 2011, two extremely premature (26 weeks gesta-
tion) infants developed fulminant MRSA sepsis and died
within a few days of each other. This paper describes the
outbreak investigation, using a novel rapid MRSA strain-
typing method.
ª2012 The Authors
Clinical Microbiology and Infection ª2012 European Society of Clinical Microbiology and Infectious Diseases
ORIGINAL ARTICLE EPIDEMIOLOGY
Methods
Design
This was a prospective study in which infection control inter-
ventions were based upon molecular typing data available in
real time.
Setting
Westmead Hospital is a 980-bed teaching hospital in Sydney,
Australia, serving a population of 1.5 million; there are c.
5500 deliveries annually. The 39-bed NICU comprises 19
high acuity ventilator cots and 20 lower acuity special care
cots; in 2011 there were 1635 admissions, including over
100 infants <1500 grams birth weight; 1066 patients were
admitted during the outbreak period (18 May 2011 to 23
January 2012). The standard nurse/bed ratio is 1:1–1:4,
depending upon staffing levels and patient acuity. There are
no single cot isolation rooms.
Patients and case definition
Outbreak cases were defined by isolation of the MRSA out-
break strain from any culture during the outbreak period. In
these infants, infection was defined by clinical and laboratory
criteria and a requirement for antimicrobial therapy, and col-
onization by absence of relevant symptoms.
Interventions
MRSA surveillance. . Previously, there had been no routine
MRSA screening in the NICU because MRSA infections were
rare. After two index cases were identified (Fig. 1), all neo-
nates and NICU staff were screened and, subsequently, neo-
nates were swabbed on admission and weekly thereafter.
Because of ongoing MRSA acquisitions, NICU staff screening
was repeated and extended to delivery room staff in Sep-
tember 2011. Swabs were collected from the anterior nares,
umbilicus (if moist) and perineum of neonates and anterior
nares, only, of staff. Mothers of colonized or infected neo-
nates were screened using nose, throat, perineal and low
vaginal swabs. Frequently touched environmental surfaces,
including door handles, trolleys, computer keyboards, ultra-
sound probes and arterial blood gas and X ray machines,
were swabbed in May and September 2011, using sterile, dry
swabs, which were inoculated directly into broth (see
below).
Decolonization regimen. . MRSA-colonized HCWs were trea-
ted with mupirocin 2% nasal ointment three times a day and
daily triclosan 1% body wash for 5 days.
Culture and strain typing
Surveillance swabs from individual infants and mothers were
inoculated, together, into a single tube of methicillin, aztreo-
nam, mannitol salt (MAMS) broth. Environmental swabs
were inoculated directly into MAMS broth. Broths were
incubated for 18 to 24 h at 35C and subcultured onto
chromogenic Brilliance MRSA selective media (Oxoid,
Basingstoke, Hants, UK). Molecular methods were also
employed for rapid detection, using the MRSA4 Easy-Plex
assay kit (AusDiagnostics, Sydney, Australia), which targeted
nuc, mecA and SCCmec-orfX; all positive samples were con-
firmed by culture. Pure cultures were stored in nutrient
broth with 20% glycerol at )70C. Isolates were identified
by routine laboratory methods [5], including antibiotic sus-
ceptibility testing performed by BD Phoenix Automated
Microbiology System (Becton Dickinson, Sparks, MD, USA).
Molecular typing studies
Isolates were typed using a novel binary typing system for
MRSA (O’Sullivan MV, Sintchenko V, Gilbert GL; personal
communication). The 19 targets for this assay were chosen
from 51 utilized in previous assays for toxin gene [6], phage-
derived open reading frame [7] and SCCmec typing [8].
Results of these assays, using a diverse local and international
collection of 165 MRSA isolates, were analysed by a specially
designed computerized algorithm (AuSeTTS, available at
(a) (b)
FIG. 1. Chest radiographs of Cases 1 and 2.
(a) Case 1: rapidly progressive necrotizing
pneumonia. (b) Case 2: overwhelming sepsis.
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http://www.cidmph.org.au/pages/AuSeTTS) (O’Sullivan MV,
Sintchenko V, Gilbert GL; submitted for publication) to iden-
tify the combination of targets with the highest discrimina-
tory power, while maintaining concordance with multilocus
sequence typing (MLST). Targets selected were four toxin
genes (sea, sec, sed and lukS-PV), nine derived from integrated
prophages (Tn554tnpB, uMu50B SAV0881, uPV83 ORF 2,
uMu50B SAV0858, u11 nt 4427-5251, uSLT ORF 257,
uN315 SA1801, uMu50A SAV1974 and uSLT ORF 182) and
six SCCmec elements (ccrAB, ccrC, mecR1, E007, CQ002 and
cadB) plus nuc (S. aureus control) and mecA (MRSA control).
All targets were amplified in a single multiplex PCR reaction;
products were hybridized to probes on a reusable nylon
membrane and detected by chemiluminesence, visualized on
X-ray film [9]. Results were expressed as a 19-digit binary
number, converted to a decimal code for ease of interpreta-
tion. The method’s discriminatory power (Simpson’s index of
diversity, D = 0.994; 95% CI, 0.988–1.00) was similar to that
of PFGE (D = 0.987; 95% CI, 0.977–0.998) and higher than
that of spa typing (D = 0.926; 95% CI, 0.879–0.972) and its
concordance with MLST was high (adjusted Wallace coeffi-
cient 0.993; 95% CI, 0.986–1.000 [10]). The assay was per-
formed weekly and, during the outbreak investigation,
selected isolates from the NICU were further characterized.
Pulse field gel electrophoresis (PFGE) was performed
according to the harmony protocol [11]; patterns were
examined using BIONUMERICS v3.00 software (Applied Maths,
Sint-Martens-Latem, Belgium). PFGE types were defined by
indistinguishable patterns (100% similarity). spa typing [6] and
MLST [12] were performed according to previously pub-
lished methods. SCCmec subtyping was performed using
mPCR/RLB assay [8]; subtypes were assigned as proposed by
Chongtrakool et al. [13].
Results
Between 18 May 2011 and 23 January 2012, 20 MRSA colo-
nized or infected neonates (including three sets of twins)
were identified in the NICU (Fig. 2). Fifteen were outbreak
cases, of whom four had MRSA infection: one each with
purulent ear discharge and severe pneumonia and the two
index cases, with fatal sepsis.
Case 1 had rapidly progressive sepsis and necrotizing
pneumonia, with pneumatocoeles. MRSA was isolated from
tracheal aspirate and urine but not blood. Case 2 developed
overwhelming sepsis, with MRSA in blood and CSF, 2 days
after MRSA had been isolated from a nasal lesion. Both
infants were treated empirically with vancomycin at the
onset of symptoms and later with linezolid and/or clindamy-
cin. Clinical presentations and outcomes of all 20 cases (see
below) are summarized in Table 1.
In May 2011, surveillance cultures were collected from
138 NICU HCW; two (staff A and B) were colonized and
successfully decolonized. In June 2011, a bundle of enhanced
infection control measures was implemented: MRSA-
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FIG. 2. Outbreak timeline between 18 May 2011 until 23 January 2012. PPE, personal protective equipment; HH, hand hygiene; HCW, health-
care worker.
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colonized infants were placed on contact precautions and co-
horted until discharge; and a unit-wide review of hand
hygiene practices, staff education on ‘5 Moments of Hand
Hygiene’ (Fig. 2) and enhanced environmental cleaning of the
MRSA-colonized patient rooms were implemented.
Despite these measures, there was ongoing MRSA acquisi-
tion, including by three infants (twins and a singleton) who were
positive on admission to the NICU, following Caesarean section
delivery. Therefore, a second bundle of measures was imple-
mented in September 2011. Additional or repeat MRSA screen-
ing of NICU staff was extended to staff in the delivery suite.
Two of 146 NICU HCW (20 doctors, 107 nurses and 19 patient
support assistants, technicians and cleaning staff) screened were
colonized (staff C and D; both were negative in June). Two of 83
delivery suite staff (26 obstetricians, 33 midwives, 23 anesthetic
staff and one other) screened were colonized (staff E and F). All
colonized staff were successfully decolonized.
Accredited auditors performed daily ‘5 moments’ hand
hygiene audits and compliance improved from 81% in Sep-
tember to 95% in January 2012; audits were subsequently
performed weekly. Patient zones were physically demarcated
to improve adherence to contact precautions. Additional
environmental screening yielded MRSA from three of 52
swabs: a blood gas machine, a milk trolley and a curtain. Five
of 13 mothers (38%; 95% CI 31–45%) and both of two
fathers screened were MRSA colonized (see Table 2).
Molecular typing results
RLB binary typing identified 18 indistinguishable MRSA iso-
lates (the ‘outbreak’ strain) from 15 neonates, one HCW
(staff C), one father and one arterial blood gas machine swab
(Table 2). This strain was PVL positive, ST 22, SCCmec sub-
type IV.3.1.2 (or IVc) and spa type t005. The PFGE patterns
of these isolates were indistinguishable.
All colonized mothers carried non-outbreak strains, three
of which matched those of their infants. The other two
were mothers of outbreak cases (6 and 7). Staff C, who was
colonized with the outbreak strain, had cared for outbreak
cases 3 and 4. Staff D was colonized with the same non-out-
break strain as case 8, whom she had nursed. This multi-
resistant strain was identified as ST772-V, spa type t657
(Bengal Bay clone). Six non-outbreak isolates with indistin-
guishable RLB types were isolated from a midwife (Staff F),
three babies (cases 5, 9 and 14), one mother (9) and a deliv-
ery suite curtain. Apart from the mother/baby pair (case 9),
there were no apparent epidemiological links; staff F was
not involved in delivery of those babies. These strains were
typical of ST1-IV (USA400 or WA-MRSA-1), which is the
second most common community-associated MRSA clone in
Australia [14].
Discussion
We documented sustained nosocomial transmission of a vir-
ulent MRSA PVL-positive ST22-MRSA-IV in our NICU, affect-
ing 15 neonates, one father and one HCW over a 7-month
period. This is the first report of a nosocomial outbreak due
to this clone in Australia. PVL, which is thought to be impor-
tant in pathogenesis [15,16], probably contributed to fatal
necrotizing pneumonia with pneumatocoele formation, in
one index case, and to septic shock and bullous lung
abscesses in the other.
We demonstrated the utility of our novel mPCR/RLB typ-
ing method, to rapidly identify nosocomial transmission and
define the outbreak by excluding MRSA-colonized infants
carrying non-outbreak strains. Traditional MRSA typing
methods are too expensive, too slow (PFGE, MLST) and/or
have insufficient discriminatory power (MLST) for routine
use. spa typing has been used, prospectively, to identify nos-
ocomial transmission events [17] but is unsuitable in our
institution, where the dominant MRSA clone (ST239-III)
belongs to a single spa type (t037). Our binary typing
method has a turnaround time of 12 h and high discrimina-
tory power; it is inexpensive (US$2 per isolate) and up to
80 isolates can be typed in a single run, using two mem-
branes. It allows targeted infection control interventions to
be implemented promptly.
The index cases shared a room; it was not clear who was
colonized first, but transmission between them, by HCW or
fomites, was assumed. Their mothers were not screened;
one may have acquired infection through vertical transmis-
sion or from an unidentified HCW. No common source for
subsequent cases was found; it was unlikely to have been
the HCW colonized with the outbreak strain, after a previ-
ously negative screen. The outbreak strain was isolated from
only one of more than 50 environmental swabs, but demon-
strates the potential for MRSA to be transmitted via fomites
and the need for targeted environmental cleaning and
enhanced hand hygiene. Twelve of 15 outbreak cases were
delivered by Caesarean section, including three colonized
within 24 h of birth, suggesting acquisition by some from a
delivery suite source, as well as transmission within the
NICU.
Further evidence favouring nosocomial, rather than verti-
cal, transmission was that mothers of two outbreak cases
were colonized with non-outbreak strains, whereas colo-
nized mothers of babies with non-outbreak strains carried
the corresponding strain. Several studies have suggested that
maternal vaginal MRSA colonization leading to neonatal infec-
tion is uncommon [18–20].
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Binary typing showed, and formal MLST, spa and SCCmec
typing confirmed, that the outbreak strain was PVL positive
and unrelated to the usual nosocomial clones seen in our
institution (AUS2/3 [ST239 MRSA-III] and UK-EMRSA15
[ST22-MRSA IV]). PFGE confirmed that the outbreak isolates
were indistinguishable. PVL-positive ST22 MRSA has been
rarely identified, previously, in Australia [14].
ST22-MRSA-IV is generally synonymous with UK-EMRSA-
15, which emerged in hospitals in the United Kingdom in
1991 [21], was subsequently identified in Germany where it
has become the predominant MRSA clone [22] and has
spread to hospitals and long-term care facilities, worldwide.
It is characteristically ciprofloxacin resistant and gentamicin
susceptible, may produce enterotoxin C but rarely PVL, har-
bours SCCmec subtype IVh and has spa type t022 or t032
(or a related variant) [23].
Our outbreak strain differs from EMRSA-15; it has a
different SCCmec subtype (IV3.1.2 or IVc), spa type (t005),
antibiogram (resistant to gentamicin and trimethoprim-
sulphamethoxazole but susceptible to ciprofloxacin) and
produces PVL, but not enterotoxin C. It has been reported
in the United Kingdom [24,25] and Japan [26], where the
index case reported recent travel to India. An outbreak of
breast abscesses in postpartum women in Mumbai, India, was
due to a similar MRSA clone, differing only by a single nucle-
otide polymorphism in one spa repeat [27]. There was no
known link with the Indian subcontinent in our cases, but
staff and patients at our institution come from a broad range
of ethnic backgrounds, so recent importation of this clone
remains a possibility.
Considering the large number of differences in the non-
core genome, this clone probably arose from ST22-MSSA,
independently of EMRSA-15 [24]. An outbreak of PVL-posi-
tive ST-22 MSSA with the same spa type and antibiogram has
been reported from Italy, also amongst postpartum women
and neonates [28].
The methods we used for MRSA screening included both
PCR and broth enrichment to optimize turn-around time
and sensitivity, followed by subculture. Previous studies sug-
gest that PCR-based screening has high sensitivity but low
reproducibility in neonates and that a combined approach,
with confirmatory culture, is preferable [29]. For optimal
neonatal screening, the combination of umbilical and nasal
swabs has a reported sensitivity of >90% [30]. The screening
protocol we used (pooled ear, nose, umbilicus and peri-
neum) should have similar sensitivity. However, only nasal
swabs were collected from staff, which may explain the
major limitation of this investigation, namely our failure to
identify a source, despite extensive screening of those
involved in delivery and care of these infants.
Among the mothers of colonized infants screened for
MRSA, the carriage rate (of non-outbreak strains) was high
(38%). Previous reports suggest overall anovaginal MRSA car-
riage rates of 2–4%, with low rates of vertical transmission
of MRSA infection to neonates [18,19]. Systematic screening
is required to determine the true MRSA carriage rates in
our antenatal population but was beyond the scope of this
study.
Non-multiresistant MRSA is an emerging pathogen in the
NICU, and can cause outbreaks with significant mortality.
The virulent PVL-positive ST22-MRSA-IV strain that caused
this outbreak was difficult to control, despite timely use of a
novel typing system, which allowed accurate definition of the
outbreak, and implementation of targeted infection control
interventions that have, apparently, finally terminated the
outbreak. At the time of writing there have been no new
acquisitions of the outbreak strain for more than 4 months.
EMRSA-15 is not the only ST22-MRSA-IV clone with epi-
demic potential.
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